ZURICH (Reuters) – Scientists who normally focus on fixing defective genes said on Friday that up to $2.1 million from the Bill & Melinda Gates Foundation will help them move their COVID-19 vaccine candidate toward 2021 human trials.Slideshow ( 2 images )Harvard University scientist Luk Vandenberghe and University of Pennsylvania gene therapy head James Wilson […]